Cancer vaccines : sixth international symposium /
Saved in:
| Meeting name: | International Cancer Vaccine Symposium (6th : 2008 : New York) |
|---|---|
| Imprint: | Boston, MA : Published by Blackwell Pub. on behalf of the New York Academy of Sciences, c2009. |
| Description: | vi, 121 p. : ill. ; 25 cm. |
| Language: | English |
| Series: | Annals of the New York Academy of Sciences, 0077-8923 ; v. 1174 |
| Subject: | |
| Format: | E-Resource Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/7887294 |
Table of Contents:
- Some scientific and organizational challenges in cancer immunology
- The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells
- Brain tumor immunotherapy with type-1 polarizing strategies
- Harnessing human dendritic cell subsets to design novel vaccines
- Dendritic cell-based vaccines for pancreatic cancer and melanoma
- Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers
- Witch hunt against tumor cells enhanced by dendritic cells
- Harnessing CD1D-restricted t cells toward antitumor immunity in humans
- Immunity against cyclin B1 tumor antigen delays development of spontaneous cyclin B1-positive tumors in p53-/- mice
- Targets of protective tumor immunity
- Identification of immunologic biomarkers associated with clinical response after immune-based therapy for cancer
- Harnessing dendritic cells to generate cancer vaccines
- Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells
- Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model
- Hematopoietic stem and progenitor cells and the inflammatory response.
